Skip Ribbon Commands
Skip to main content
SharePoint
 
 
ICER to use Pharmerit model in new rheumatoid arthritis framework
The Institute for Clinical and Economic Review (ICER) announced that it will rely in part on a model developed by Pharmerit to assess the cost-effectiveness of rheumatoid arthritis treatments.
 
Pharmerit publishes economic analysis of treatment strategies for patients with suspected fungal infections in the People’s Republic of China.
This study analyses the results of the diagnostic-driven treatment approach compared to an empirical driven approach for invasive fungal infections.

 Latest news

2016-08-30
The Institute for Clinical and Economic Review (ICER) announced that it will rely in part on a model developed by Pharmerit to assess the cost-effectiveness of rheumatoid arthritis treatments.
2016-08-09
This study analyses the results of the diagnostic-driven treatment approach compared to an empirical driven approach for invasive fungal infections.

 Our people

“It is very satisfying to work at
a place that truly values and
invests in the professional
growth of its staff„
 
“There is a lot of variety in the work
I do at Pharmerit, which challenges
me to develop myself in different
areas of diseases and different
aspects of health economics.„
 
“Working at Pharmerit is generating
the best evidence, taking into
account clients’ needs and best
research practices„
 
“The fun part is working on
a diverse array of projects
and understanding how
different bits fit together to
form a complete picture„
 
 

 Meet us at

Oct
19
2016
Copenhagen, Denmark09:00 - 19:00
Oct
29
2016
Vienna, Austria09:00 - 19:00
Retrieving Data